Applications of metabolomics to study cancer metabolism

Akash K. Kaushik, Ralph J. DeBerardinis

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Reprogrammed metabolism supports tumor growth and provides a potential source of therapeutic targets and disease biomarkers. Mass spectrometry-based metabolomics has emerged as a broadly informative technique for profiling metabolic features associated with specific oncogenotypes, disease progression, therapeutic liabilities and other clinically relevant aspects of tumor biology. In this review, we introduce the applications of metabolomics to study deregulated metabolism and metabolic vulnerabilities in cancer. We provide examples of studies that used metabolomics to discover novel metabolic regulatory mechanisms, including processes that link metabolic alterations with gene expression, protein function, and other aspects of systems biology. Finally, we discuss emerging applications of metabolomics for in vivo isotope tracing and metabolite imaging, both of which hold promise to advance our understanding of the role of metabolic reprogramming in cancer.

Original languageEnglish (US)
JournalBiochimica et Biophysica Acta - Reviews on Cancer
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Metabolomics
Neoplasms
Systems Biology
Isotopes
Disease Progression
Mass Spectrometry
Biomarkers
Gene Expression
Therapeutics
Growth
Proteins

Keywords

  • And metabolite imaging
  • Cancer metabolism
  • Isotope tracing
  • Metabolic subtypes
  • Metabolomics
  • Systems biology

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Applications of metabolomics to study cancer metabolism. / Kaushik, Akash K.; DeBerardinis, Ralph J.

In: Biochimica et Biophysica Acta - Reviews on Cancer, 01.01.2018.

Research output: Contribution to journalArticle

@article{f6283a5abb1546808695d866019f26b6,
title = "Applications of metabolomics to study cancer metabolism",
abstract = "Reprogrammed metabolism supports tumor growth and provides a potential source of therapeutic targets and disease biomarkers. Mass spectrometry-based metabolomics has emerged as a broadly informative technique for profiling metabolic features associated with specific oncogenotypes, disease progression, therapeutic liabilities and other clinically relevant aspects of tumor biology. In this review, we introduce the applications of metabolomics to study deregulated metabolism and metabolic vulnerabilities in cancer. We provide examples of studies that used metabolomics to discover novel metabolic regulatory mechanisms, including processes that link metabolic alterations with gene expression, protein function, and other aspects of systems biology. Finally, we discuss emerging applications of metabolomics for in vivo isotope tracing and metabolite imaging, both of which hold promise to advance our understanding of the role of metabolic reprogramming in cancer.",
keywords = "And metabolite imaging, Cancer metabolism, Isotope tracing, Metabolic subtypes, Metabolomics, Systems biology",
author = "Kaushik, {Akash K.} and DeBerardinis, {Ralph J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.bbcan.2018.04.009",
language = "English (US)",
journal = "Biochimica et Biophysica Acta - Reviews on Cancer",
issn = "0304-419X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Applications of metabolomics to study cancer metabolism

AU - Kaushik, Akash K.

AU - DeBerardinis, Ralph J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Reprogrammed metabolism supports tumor growth and provides a potential source of therapeutic targets and disease biomarkers. Mass spectrometry-based metabolomics has emerged as a broadly informative technique for profiling metabolic features associated with specific oncogenotypes, disease progression, therapeutic liabilities and other clinically relevant aspects of tumor biology. In this review, we introduce the applications of metabolomics to study deregulated metabolism and metabolic vulnerabilities in cancer. We provide examples of studies that used metabolomics to discover novel metabolic regulatory mechanisms, including processes that link metabolic alterations with gene expression, protein function, and other aspects of systems biology. Finally, we discuss emerging applications of metabolomics for in vivo isotope tracing and metabolite imaging, both of which hold promise to advance our understanding of the role of metabolic reprogramming in cancer.

AB - Reprogrammed metabolism supports tumor growth and provides a potential source of therapeutic targets and disease biomarkers. Mass spectrometry-based metabolomics has emerged as a broadly informative technique for profiling metabolic features associated with specific oncogenotypes, disease progression, therapeutic liabilities and other clinically relevant aspects of tumor biology. In this review, we introduce the applications of metabolomics to study deregulated metabolism and metabolic vulnerabilities in cancer. We provide examples of studies that used metabolomics to discover novel metabolic regulatory mechanisms, including processes that link metabolic alterations with gene expression, protein function, and other aspects of systems biology. Finally, we discuss emerging applications of metabolomics for in vivo isotope tracing and metabolite imaging, both of which hold promise to advance our understanding of the role of metabolic reprogramming in cancer.

KW - And metabolite imaging

KW - Cancer metabolism

KW - Isotope tracing

KW - Metabolic subtypes

KW - Metabolomics

KW - Systems biology

UR - http://www.scopus.com/inward/record.url?scp=85046673959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046673959&partnerID=8YFLogxK

U2 - 10.1016/j.bbcan.2018.04.009

DO - 10.1016/j.bbcan.2018.04.009

M3 - Article

JO - Biochimica et Biophysica Acta - Reviews on Cancer

JF - Biochimica et Biophysica Acta - Reviews on Cancer

SN - 0304-419X

ER -